ライフサイエンスコーパス: seropositive

1 titer of 10 or higher were considered to be seropositive.

2 hat ~20% of persons living in the region are seropositive.

3 Out of the 250 cases, 155 (62%) were seropositive.

4 serologically screened individuals, 26% were seropositive.

5 4 years (IQR: 27-44), and 130 (28%) were HIV seropositive.

6 12 years of chronological age for those CMV seropositive.

7 Two American robins were also seropositive.

8 assay identified most patients correctly as seropositive.

9 86/124 (69.4%) mothers were found to be KSHV seropositive.

10 d nontumored Floridian turtles are uniformly seropositive.

11 915 (87.4%) were aquaporin-4 immunoglobulin seropositive.

12 s from Oregon and Washington (n = 1511) were seropositive.

13 d 97 (97%) of monovalent OPV2 vaccinees were seropositive.

14 s with NMOSD (n=39, 28 aquaporin-4 (AQP4)-Ab-seropositive, 3 double-Ab-seronegative, 4 myelin oligode

15 ticipants (n = 1,324) were predominantly HIV seropositive (68%), Black/African-American (68%) or Hisp

16 stem (PNS) manifestations, 39% were LGI1-IgG seropositive (7% had solely neuropathy or pain).

17 Seventy-one of 92 (77.2%) subjects were YFV seropositive (90 percent plaque reduction neutralization

18 of-concept open-label clinical trial, 38 CMV-seropositive AAV patients were randomized to receive val

19 though individuals in all professions tested seropositive, abattoir workers (10 of 97; 10.3%) were si

20 Seventy-one OMG patients with seropositive AchR Ab presented during July 2009 and Dece

21 OMG patients with seropositive AchR Ab should be informed that taking pyri

22 Our enrollment goal was 30 LGI1/CASPR2-IgG-seropositive adult patients with >=2 seizures per week.

23 es plasma interleukin 6 (IL-6) levels in CMV-seropositive adults who are critically ill.

24 Among CMV-seropositive adults with critical illness due to sepsis

25 ys (November 10, 2016) that included 160 CMV-seropositive adults with either sepsis or trauma and res

26 s in RSV-specific serum antibody in healthy, seropositive adults.

27 d immunogenicity in CMV-seronegative and CMV-seropositive adults.

28 t pre-existing neutralizing responses in RSV seropositive adults.

29 cholera vaccine CVD 103-HgR among H. pylori seropositive African adults provides further evidence of

30 anaian children, 121 (27.8%, 23.5-32.0) were seropositive after 2.3 years.

31 apparent, and eight participants (14%) were seropositive after hypoalbuminemia became apparent.

32 13 studies, the pooled proportion of infants seropositive after two MCV doses, with MCV1 administered

33 ally seronegative samples, 3284 (82.3%) were seropositive after vaccination for anti-mumps antibodies

34 95% confidence interval [CI], 97 to 99) were seropositive after vaccination.

35 e mortality at week 24 versus placebo in CMV-seropositive allogeneic hematopoietic cell transplantati

36 We assessed the infectiousness of HIV-seropositive and -seronegative patients with tuberculosi

37 elitis optica spectrum disorder patients (98 seropositive and 18 seronegative) in chronic disease pha

38 oid, mucosal and secretory tissues of 44 CMV seropositive and 28 seronegative donors.

39 Eleven seropositive and 284 seronegative patients completed 4 w

40 We evaluated 500 seropositive and 300 seronegative blood donor plasma sam

41 myelin oligodendrocyte glycoprotein (MOG)-Ab-seropositive and 4 AQP4-Ab-seronegative with unknown MOG

42 d for diagnosing dengue fever, 93 cases were seropositive and 67 cases were seronegative.

43 ional study, including 95 virally-suppressed seropositive and 84 demographically-matched, seronegativ

44 numerous 0.1% of clones is larger in the CMV seropositive and gradually increases with age.

45 ean follow-up of 8.2 years, we observed (HCV seropositive and HCV seronegative, respectively) 107 and

46 an immunodeficiency virus (HIV)-infected HCV-seropositive and incidence density-matched HCV-seronegat

47 ed with HHV-6 viremia in high-risk donor CMV-seropositive and recipient CMV-seronegative (D+R-) liver

48 o the matching protocol, our distribution of seropositive and seronegative donors and recipients was

49 firmed by polymerase chain reaction (PCR) in seropositive and seronegative health care workers attend

50 ion included a ratio of aquaporin-4 antibody seropositive and seronegative patients that was reflecti

51 t RA may be further subdivided beyond simply seropositive and seronegative.

52 rum and longitudinal outcome in 256 LGI1-IgG-seropositive and/or CASPR2-IgG-seropositive patients.

53 this population (eight anti-Ebola virus IgG seropositive) and report a case fatality lower than prev

54 ceding 4 weeks, of which 24.8% (25/101) were seropositive, and 60% of these were IgM+IgG-.

55 CMV reactivation occurred in 100% of seropositive animals in this model.

56 Significant spatial clustering of seropositive animals was observed in California and Wash

57 d time-efficient assay for detection of FMDV seropositive animals, regardless the FMDV serotype that

58 exposure of infected cells to IgG from RhCMV-seropositive animals, suggesting that Rh05 protects infe

59 an group, 296 (50.4%, 95% CI 46.4-54.5) were seropositive (antibody concentration >=0.5 IU/mL) 4.5 ye

60 107 of the 1215 who were tested (91.1%) were seropositive; antiviral antibody titers assayed by two p

61 UL46 are targeted by CD4(+) T cells from HSV-seropositive asymptomatic individuals (who, despite bein

62 NCE We report that naturally protected HSV-1-seropositive asymptomatic individuals develop a higher f

63 ll timepoints, and 24 of 38 (63.8%) were YFV seropositive at >=10 years after single-dose vaccination

64 cination in nearly all participants who were seropositive at 1 month after vaccination.

65 Participants who were seropositive at baseline and who had an increase in the

66 Among 223 participants who were seropositive at baseline, 148 (66%; 95% CI, 60 to 72) ha

67 95% CI 68.5 to 81.9) in individuals who were seropositive at baseline, 66.2% (49.1 to 77.5) in indivi

68 (80%) vaccine recipients were H. pylori IgG seropositive at baseline.

69 ccinated participants, 286 (97%) of 296 were seropositive at baseline; after one dose, 100% of novel

70 a baseline titer of less than 10 who became seropositive at follow-up were classified as having unde

71 st documented and 28.5% (six out of 21) were seropositive at the same time as NNRP; 66% (39 out of 59

72 sting of the salivary panel failed to detect seropositive autoantibodies against any of the salivary-

73 Seven of 12 individuals were JCV antibody seropositive based on absorbance units.

74 Nineteen recipients were CMV seropositive before BMT.

75 Twelve participants (20%) were seropositive before hypoalbuminemia became apparent, and

76 rediagnostic NNRP, 43% (nine out of 21) were seropositive before NNRP was first documented and 28.5%

77 incidence of PTLD among patients who are EBV-seropositive before transplant is lower, and little is k

78 Smokers were more likely to be HPyV9-seropositive but MCV-seronegative, and HPyV7 seropositiv

79 ays post symptom onset with >50% of patients seropositive by at least one antibody isotype after Day

80 3-23.2) of symptomatic participants who were seropositive by both the point-of-care test and immunoas

81 Individuals who are falsely identified as seropositive by dengue IgG ELISA and then vaccinated mig

82 MERS-CoV seronegative and seropositive camels received a single intramuscular dose

83 Antibody responses in seropositive camels were enhancedby the vaccine; these c

84 A majority of adults in Finland are seropositive carriers of herpes simplex viruses (HSV).

85 During 2016, GDPH interviewed 243 seropositive case patients; only 28% (n = 69) met inclus

86 The age range of the seropositive cases was 1 to 78 years with the mean age o

87 We here assess DS-Cav1 F immunogenicity in seropositive cattle pre-exposed to bovine RSV, a virus c

88 V-serostatus (11 [48%] of 23 symptomatic HIV-seropositive child contacts vs two [7%] of 31 asymptomat

89 contacts vs two [7%] of 31 asymptomatic HIV-seropositive child contacts) or to only culture-confirme

90 Most seropositive children (6/8) were not suspected of having

91 at 106 plaque-forming units (PFU) in 15 RSV-seropositive children and at 105 and 106 PFU in 21 and 3

92 The sera of seropositive children have neutralizing activity, includ

93 Victoria, with 94% of infections and 93% of seropositive children in communities <1.5 km from the la

94 The number of seropositive children increased to 188 (43.1%, 95% CI 38

95 ally differentiated CD57+KLRG1+ cells in CMV seropositive (CMV+) individuals.

96 ore antibodies against CMV pp150 than do CMV-seropositive controls.

97 One hundred sixty donor/recipient CMV-seropositive (D+/R+) patients, stratified by their basel

98 shmania infantum, is a zoonosis, and culling seropositive dogs has been recommended to control the di

99 In 583 kidney transplant recipients (260 seropositive donor [D+]/seronegative recipient [R-] and

100 ted that HHV-8 was likely transmitted by the seropositive donor at the time of transplantation.

101 8-DNA was detected in 6.8% and 2.9% of HHV8-seropositive donor samples by in-house nested PCR and qu

102 plant, 3 (25%) of 12 HHV8-mismatch patients (seropositive donor/seronegative recipient) developed a p

103 eronegative liver transplant recipients with seropositive donors aged older than 18 years.

104 Most seropositive donors had a titer of 64; only 3.1% (n = 93

105 eronegative liver transplant recipients with seropositive donors, high rates of delayed-onset postpro

106 eronegative liver transplant recipients with seropositive donors, the use of preemptive therapy, comp

107 V-1/2 IgG in 14% (5/36) of OF specimens from seropositive donors.

108 D4(+) TH1 proliferation response only in CMV-seropositive donors.

109 31 of 34 renal transplant biopsies from HCMV-seropositive donors.

110 Sixteen (67%) of 24 OMG patients who were seropositive for acetylcholine receptor antibody (AchR A

111 in seroprevalence, at least 9% of males were seropositive for at least 1 of the 4 HPV types.

112 9 (3.8%) had IRB for BBV and 285 (1.7%) were seropositive for BBV, of whom half had a history of IRB

113 ong predictor of CNS involvement in patients seropositive for CASPR2-IgG or LGI1-IgG.

114 There were decreases in proportion seropositive for every HPV type across all age groups, m

115 Two of 207 (1%) participants were seropositive for H5 and 4 of 207 (2%) for H7 in 2011, co

116 Among state veterinarians, 4 of 37(11%) were seropositive for H7 and 1 of 37 (2.7%) for H5.

117 fication showed that 31.0% of the males were seropositive for HCV while 15.4% of the females were ser

118 6%] of the participating prison inmates were seropositive for HCV.

119 tive for HCV while 15.4% of the females were seropositive for HCV.

120 and 28.3% who had multiple sex partners were seropositive for HCV.

121 1%) of 506 in the measles-rubella group were seropositive for measles; eight (2%) infants in the meas

122 CHR subjects were not more frequently seropositive for neuronal autoantibodies than controls (

123 At baseline, 15 patients were seropositive for NMDAR antibodies and 372 were seronegat

124 5.1% (95% CI 4.8-5.4) were seropositive for P knowlesi, and marked historical decre

125 64% were seropositive for Phlebotomus alexandri saliva antibodies

126 me time as NNRP; 66% (39 out of 59) of those seropositive for PLA2R-AB had hypoalbuminemia present at

127 in the mass dengue vaccination campaign were seropositive for previous dengue virus infection.

128 dren were dengue naive and 2676 (89.3%) were seropositive for previous dengue virus infection.

129 two (<1%) in the measles-rubella group were seropositive for rubella.

130 ak strain, 86.9% (95% CI, 75.8 to 94.2) were seropositive for the 44/76-SL strain, for which there wa

131 f these vaccinees (95% CI, 94.1 to 100) were seropositive for the 5/99 strain and had a higher geomet

132 Bats were seropositive for the isolated viruses.

133 La in SS, but only a few ICIS patients were seropositive for these autoantigens.

134 follow-up, 666 (97%; 95% CI, 96 to 98) were seropositive for yellow fever antibody.

135 fever revaccination were included; children seropositive for yellow fever at baseline were excluded.

136 itive with ELISA, seven samples (63.6%) were seropositive for Zika virus or Japanese encephalitis vir

137 % CI, 70%-86%) of vaccinees are likely to be seropositive >=10 years postvaccination.

138 sion from seronegative (<1:8) at baseline to seropositive (>1:8) after vaccination or boosting titers

139 sion from seronegative (<1:8) at baseline to seropositive (>=1:8) or four-fold increase in reciprocal

140 , 42.3% of HU and 46.4% of HEU children were seropositive (>=330 mIU/mL).

141 of patients with FEP who are NMDAR antibody seropositive have coexisting cerebrospinal fluid inflamm

142 es in 3 clinically distinct subgroups of CMV-seropositive HCT patients: (1) Elite Controllers (n = 19

143 123 while symptomatic, whereas 2 anti-spike-seropositive health care workers had a positive PCR test

144 tibody titres was observed in a cohort of 31 seropositive healthcare workers.

145 as well as 26 HCMV-seronegative and 39 HCMV-seropositive healthy controls.

146 dred fifty-six hepatitis B e antigen (HBeAg)-seropositive, hepatitis B surface antigen (HBsAg) carrie

147 +) T cell response was common among both EBV-seropositive HLA-B*07:02(+) healthy and immunocompromise

148 maintenance of infection of RhCMV, even in a seropositive host, as shown by the induction of T cell r

149 Treating everyone within seropositive households (63% population) would target 77

150 OF and plasma specimens were obtained from seropositive HTLV-1/2-infected patients attending the Na

151 ed if the altered NK cell compartment in CMV-seropositive human donors may affect CMV-specific CD8 T

152 (14%), 9/27 (32%), and 12/19 (37%) remained seropositive in 1-7, 8-15, and 16-18 months age groups,

153 ld was seropositive in March, but seven were seropositive in April for a period seroprevalence of ~1%

154 Only one child was seropositive in March, but seven were seropositive in Ap

155 After the second dose, the proportion seropositive increased to 99.0% in HU and 95.3% in HEU c

156 Here, whole blood of healthy seropositive individuals (n = 75), living in N.

157 provides protection against severe dengue in seropositive individuals but increases the risk for naiv

158 Across age groups, cytomegalovirus seropositive individuals displayed immunotypes character

159 rization revealed memory T cell responses in seropositive individuals for a substantial proportion (2

160 evaluated 1201 human immunodeficiency virus-seropositive individuals hospitalized with suspected men

161 The percent of seropositive individuals increased with time, peaking in

162 A highly reproducible finding in CMV-seropositive individuals is an expansion of NKG2C(pos) N

163 HIV-1 transgenic (Tg) rat, resembling HIV-1 seropositive individuals on lifelong cART, exhibits age-

164 ative controls was detected in 24 of 68 KSHV-seropositive individuals tested.

165 The MS risk increase in ANO2-seropositive individuals was dramatic when also exposed

166 CMV-seropositive individuals with iciHHV-6A/B(+) have more a

167 Among the 55 seropositive individuals, antibodies were directed most

168 marked increase in life expectancy for HIV-1 seropositive individuals, following the great success of

169 Among HCV-seropositive individuals, treated participants without S

170 but is only present in cytomegalovirus (CMV)-seropositive individuals.

171 als before vaccination, and vaccinating only seropositive individuals.

172 ibition; deficits commonly observed in HIV-1 seropositive individuals.

173 ed a number of mutations present only in HIV seropositive individuals.

174 antigen targeted by CD8(+) T cells from HSV-seropositive individuals.

175 ertoire of anti-HCMV T cell specificities in seropositive individuals.

176 how a large decrease from the proportions of seropositive infants 28 days after vaccination, 96.7% in

177 Our outcome measures were proportion of seropositive infants, geometric mean titre, vaccine effi

178 Healthy VZV-seropositive Kenyan women (n = 44) were immunized with h

179 ransplant candidates willing to accept a HCV-seropositive kidney increased from 2936 to 16,809 from d

180 CMV-seropositive lung transplantation recipients were includ

181 ific T-cell responses in breast milk of HCMV-seropositive mothers is not well defined.

182 Infants of seropositive mothers underwent diagnostic testing with q

183 Of the 1,325 infants of seropositive mothers, 65 infants (4.9%) were diagnosed w

184 ealed several natural point mutations in HIV seropositive/negative individuals.

185 MOG-IgG-associated disorder in 5%, AQP4-IgG-seropositive neuromyelitis optic spectrum disorder (NMOS

186 Thirty-nine patients with aquaporin 4-IgG seropositive NMOSD (age: 50.1+/-14.1 years, 36 women, 25

187 lated, particularly in patients with AQP4-Ab-seropositive NMOSD (r(s)=0.70, p<0.001).

188 Those derived from three anti-AQP4-IgG seropositive NMOSD patients (n = 130) were compared to 7

189 attern of elevation in patients with AQP4-Ab-seropositive NMOSD.

190 .6% of cases and 7.8% of controls being ANO2 seropositive (odds ratio [OR] = 1.6; 95% confidence inte

191 % of controls and 41% of cases were H pylori-seropositive (odds ratio [OR], 1.09; 95% CI, 0.99-1.20).

192 Of quarantined persons, 2.3% were seropositive; of those with unknown exposure, 0.3% were

193 A high proportion of seropositive OLM cases had uveitis (34.19%) followed by

194 The most frequent clinical presentation of seropositive OLM cases were unilateral reduced vision an

195 tigen using matched T cells and MCs from CMV-seropositive or CMV-seronegative donors, and for antigen

196 men on antiretroviral therapy who were HSV-2 seropositive or seronegative and HIV-uninfected controls

197 s aged 18-74 years with aquaporin-4 antibody seropositive or seronegative NMOSD at 44 investigational

198 ficantly worse in patients who were AQP4-IgG seropositive (p=0.034), but there was no relationship be

199 We included 2503 HCV-seropositive participants (540 with spontaneous HCV clea

200 re included in the analytic sample (2278 HIV-seropositive participants contributed 20 477 visits and

201 Compared with HCV-negative controls, HCV-seropositive participants had an increased risk of liver

202 Around a third of seropositive participants were asymptomatic, ranging fro

203 % to 27.7% (P < .001), and 48.4% of unlinked seropositive participants were linked to HIV care throug

204 Seropositive participants were more likely to require as

205 nsional T1-weighted spinal cord MRI scans in seropositive participants with NMOSDs and in age-matched

206 Among the total 668 seropositive participants, 433 (64.8%) had previously be

207 tis D virus RNA among anti-hepatitis D virus seropositive participants.

208 pediatric dialysis unit after contact with a seropositive patient.

209 -lymphocytic encephalitis in an anti-Drebrin-seropositive patient.

210 was found in 44% of LGI1-IgG/CASPR2-IgG dual seropositive patients (one-third thymoma).

211 cing lesions from 284 aquaporin-4 (AQP4)-IgG seropositive patients at Mayo Clinic from 1996 to 2014.

212 Seropositive patients had higher absolute eosinophil cou

213 sease activity, while 14% of cytomegalovirus-seropositive patients had reactivation.

214 The seropositive patients had similar symptom profiles and d

215 ailable from 96 of 118 consecutive PCA-2-IgG-seropositive patients identified during 1993-2016.

216 Two LGI1-IgG-seropositive patients receiving IVIG, but none receiving

217 population, we found that 9.2% (8.7-9.8) of seropositive patients were diagnosed.

218 utoantibodies against glutamatergic NMDAR in seropositive patients who cannot be clinically identifie

219 gG serostatus was longitudinally assessed in seropositive patients with available serum samples and a

220 Recent data highlight the presence, in HIV-1-seropositive patients with lymphoma, of p17 variants (vp

221 possible cause of neurodegeneration in HIV-1-seropositive patients, which engages the ability of p17

222 cerebrospinal fluid occurred in anti-Drebrin-seropositive patients.

223 256 LGI1-IgG-seropositive and/or CASPR2-IgG-seropositive patients.

224 aphic factors and clinical manifestations of seropositive patients.

225 The seropositive person reported multiple direct cat exposur

226 NS3-1073 and NS5-2594 were expanded from HCV-seropositive persons by peptide stimulation in vitro or

227 VI) to permanent hearing loss (HL) in highly seropositive populations is unknown.

228 larify the natural history of cCMV in highly seropositive populations, which, in almost all populatio

229 one third of all early-onset hearing loss in seropositive populations.

230 valence of cCMV is high (>=7:1000) in highly seropositive populations.

231 90 of 329 (27.4%) vs 107 of 472 (22.7%) were seropositive postvaccination (absolute difference, 4.7%

232 Prospective study involving 144 T. cruzi seropositive pregnant women.

233 sensitivity for secondary, early latent, and seropositive primary syphilis.

234 Since children born to women who are seropositive prior to pregnancy are less likely to be af

235 Only three crew members tested seropositive prior to the boat's departure in initial se

236 le to participate if they were confirmed HIV-seropositive, qualified for first-line ART, planned to r

237 c complex (PC) and the ADCC response in HCMV-seropositive (R+) LTRs and in seronegative recipients of

238 Compared with a 92.2% seropositive rate among 1057 persons hired at age >50 ye

239 e results of this testing demonstrated a low seropositive rate, as determined by standard two-tiered

240 ention of CMV disease in high-risk donor CMV seropositive/recipient seronegative.

241 ly been directly compared in high-risk donor-seropositive/recipient-seronegative (D+R-) organ transpl

242 Two of 93 HHV8-seropositive recipients (2.1%) had viral replication in

243 tatus, with highest gains in naive donors to seropositive recipients for several human herpesviruses

244 or prophylaxis of CMV infection in adult CMV-seropositive recipients of allogeneic hematopoietic stem

245 Rate of reactivation among seropositive recipients was 2.2 and 16%.

246 -seronegative recipients, versus 69 into HCV-seropositive recipients, while 105 HCV-viremic kidneys w

247 In patients who were seropositive, reduction in seizure frequency was associa

248 pregnant women and treatment of those found seropositive remains limited in sub-Saharan Africa.

249 on; 11, possible infection; 18, asymptomatic seropositive result); and 17 had only positive findings

250 Only 52.4% of SARS-CoV-2 seropositive retired blood donors reported having been s

251 B cells are postulated to be central in seropositive rheumatoid arthritis (RA).

252 unexpected contrast to vaccination of RhCMV-seropositive RM.

253 CI = 2.05-41.32), as did people who were HIV seropositive (RR = 4.06, 95% CI = 1.42-11.56).

254 increased at different rates in both groups; seropositive samples were found as early as mid-February

255 Seropositive samples were tested with commercial and vet

256 fferent time points after disease-onset, and seropositive sera to other human coronaviruses (CoVs).

257 arasitology are also diagnosed in the field (seropositive [SERO]).

258 NT5c1A seropositive sIBM cases had lower total Medical Research

259 Participants with seropositive sIBM took significantly longer to get up an

260 -year post-transplantation, 29/823 (3.5%) of seropositive SOT recipients had seroreverted, and 63/111

261 Country of birth was known for 255 seropositive specimens, which were grouped into regions

262 Half of all seropositive staff had been tested positive by PCR prior

263 ation after cardiac death, hepatitis B and C seropositive status, cigarette use, diabetes, hypertensi

264 formance of a kidney biopsy, cytomegalovirus seropositive status, donation after cardiac death, hepat

265 For the LGI1-IgG seropositive subgroup, 6 of 8 patients in the IVIG group

266 at within the CHR sample, the NMDAR antibody seropositive subjects had higher levels of current depre

267 immune responses analogous to those of HCMV-seropositive subjects may confer protection against cong

268 attributes similar in quality to those from seropositive subjects, including high-avidity antibodies

269 frequencies comparable to those seen in HCMV-seropositive subjects.

270 requencies comparable to those of three HCMV-seropositive subjects.

271 tional attributes similar to those from HCMV-seropositive subjects.

272 -C cohort, 17 (68%) children were SARS-CoV-2 seropositive, suggesting previous SARS-CoV-2 infections(

273 genome-wide epitopes were compared in HSV-1-seropositive symptomatic individuals (with a history of

274 necessity for protection from reinfection), seropositive test results should not be used to inform i

275 rom Hawaii actively shedding ChHV5 were more seropositive than nonshedders.

276 78]) had a significantly lower risk of being seropositive than those aged 20-49 years.

277 nversion was markedly higher among H. pylori seropositives than seronegatives 64% vs. 26% (p = 0.004)

278 results classified as dengue seronegative or seropositive, the ELISA (with a 0.9 index value cutoff)

279 Turtles from Florida were uniformly seropositive to ChHV5 regardless of tumor status.

280 immunoglobulin G antibody levels among those seropositive to CMV were also associated with shorter LT

281 nd a similar proportion of subjects remained seropositive to homologous MSP-1(42) >5 months after CHM

282 tralian states and calculated the proportion seropositive to HPV types 6, 11, 16, and 18.

283 Approximately 97% of the population was seropositive to tetanus and diphtheria as defined by a p

284 5) or AP (n = 25) and a control group of CMV-seropositive transplant recipients (R+) (AP; n = 24).

285 We describe the characteristics of EBV-seropositive transplant recipients (R+) who developed PT

286 A total of 29 MZ and 22 DZ HSV-1-seropositive twin pairs were evaluated for oral HSV-1 sh

287 Ninety-three HSV-2-seropositive Ugandan adults collected anogenital swab sp

288 HBeAg-seropositive vaccine failure HBV-carrier children were a

289 Among H. pylori seropositive vaccine recipients, there were no significa

290 ccording to serostatus at baseline (89.5% in seropositives versus 21.6% in seronegatives).

291 otent (Neut50 < 0.1 mug/ml) nAbs from a DENV-seropositive volunteer immunized with the tetravalent va

292 h a seropositivity rate of 9.9% (90/905); 61 seropositives who were newly identified or never treated

293 We compared (1) HCV-seropositive with HCV-seronegative participants and (2)

294 imately one third of the participants became seropositive within 3 months of MN diagnosis.

295 ART-suppressed, HIV seropositive women (n = 22) were matched 1:1 to 22 of 39

296 intervention clinics and 43.2% (2.6-83.2) of seropositive women in control clinics (absolute differen

297 done in a median of 100% (IQR 99.7-100.0) of seropositive women in intervention clinics and 43.2% (2.

298 ne response resembling the responses in HCMV-seropositive women may be effective.

299 Among 49 ulcer specimens from 49 HSV-2 seropositive women, by PCR HSV-2 was recovered from 28 (

300 Among 487 infants of 476 seropositive women, congenital T. cruzi infection was de

301 on is much lower in naturally infected (HCMV-seropositive) women, we hypothesize that a vaccine candi